Managing cardiovascular outcomes in patients with type 2 diabetes – Where have we come from and where are we going?
Congress Presentation
About the speaker
Professor Darren Keith McGuire
6 more presentations in this session
Introduction – Improving cardiovascular outcomes in patients with type 2 diabetes: where does the evidence lead us?
Speaker: Professor N. Marx (Aachen, DE)
Cardiovascular risk reduction with empagliflozin: exploring the evidence from EMPA-REG OUTCOME®.
Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)
Using empagliflozin in your patients with type 2 diabetes:
considerations for daily patient care.
Speaker: Doctor J. Udell (Toronto, CA)
Experience with empagliflozin: insights from practice.
Speaker: Professor N. Marx (Aachen, DE) Professor D. McGuire (Dallas, US) Professor F. Zannad (Vandoeuvre-Les-Nancy, FR) Doctor J. Udell (Toronto, CA)
Access the full session
Improving cardiovascular outcomes in patients with type 2 diabetes: where does the evidence lead us?
About the event
